649 related articles for article (PubMed ID: 2743332)
1. Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay.
Plumb JA; Milroy R; Kaye SB
Cancer Res; 1989 Aug; 49(16):4435-40. PubMed ID: 2743332
[TBL] [Abstract][Full Text] [Related]
2. Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production.
Vistica DT; Skehan P; Scudiero D; Monks A; Pittman A; Boyd MR
Cancer Res; 1991 May; 51(10):2515-20. PubMed ID: 2021931
[TBL] [Abstract][Full Text] [Related]
3. A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity.
Twentyman PR; Luscombe M
Br J Cancer; 1987 Sep; 56(3):279-85. PubMed ID: 3663476
[TBL] [Abstract][Full Text] [Related]
4. Noncolorimetric measurement of cell activity in three-dimensional histoculture using the tetrazolium dye 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide: the pixel image analysis of formazan crystals.
Colangelo D; Guo HY; Connors KM; Silvestro L; Hoffman RM
Anal Biochem; 1992 Aug; 205(1):8-13. PubMed ID: 1443562
[TBL] [Abstract][Full Text] [Related]
5. Ammonia-containing dimethyl sulfoxide: an improved solvent for the dissolution of formazan crystals in the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay.
Wang H; Wang F; Tao X; Cheng H
Anal Biochem; 2012 Feb; 421(1):324-6. PubMed ID: 22100715
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines.
Scudiero DA; Shoemaker RH; Paull KD; Monks A; Tierney S; Nofziger TH; Currens MJ; Seniff D; Boyd MR
Cancer Res; 1988 Sep; 48(17):4827-33. PubMed ID: 3409223
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a rapid tetrazolium-based colorimetric assay for selecting anticancer drugs.
Chen CF; Hwang JM; Wu CH; Chen CS; Chen KY
Zhonghua Yi Xue Za Zhi (Taipei); 1990 Jul; 46(1):7-16. PubMed ID: 2176928
[TBL] [Abstract][Full Text] [Related]
8. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture.
Cory AH; Owen TC; Barltrop JA; Cory JG
Cancer Commun; 1991 Jul; 3(7):207-12. PubMed ID: 1867954
[TBL] [Abstract][Full Text] [Related]
9. Improved Formazan Dissolution for Bacterial MTT Assay.
Benov L
Microbiol Spectr; 2021 Dec; 9(3):e0163721. PubMed ID: 34937171
[TBL] [Abstract][Full Text] [Related]
10. Amyloid beta protein inhibits cellular MTT reduction not by suppression of mitochondrial succinate dehydrogenase but by acceleration of MTT formazan exocytosis in cultured rat cortical astrocytes.
Abe K; Saito H
Neurosci Res; 1998 Aug; 31(4):295-305. PubMed ID: 9809588
[TBL] [Abstract][Full Text] [Related]
11. Adaptation of the rapid automated tetrazolium dye based (MTT) assay for chemosensitivity testing in childhood leukemia.
Pieters R; Huismans DR; Leyva A; Veerman AJ
Cancer Lett; 1988 Aug; 41(3):323-32. PubMed ID: 3165705
[TBL] [Abstract][Full Text] [Related]
12. The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part I: Evaluation of test-specific variables.
Nikkhah G; Tonn JC; Hoffmann O; Kraemer HP; Darling JL; Schönmayr R; Schachenmayr W
J Neurooncol; 1992 May; 13(1):1-11. PubMed ID: 1613535
[TBL] [Abstract][Full Text] [Related]
13. Rapid chemosensitivity testing of human lung tumor cells using the MTT assay.
Cole SP
Cancer Chemother Pharmacol; 1986; 17(3):259-63. PubMed ID: 3742711
[TBL] [Abstract][Full Text] [Related]
14. Comparison of tetrazolium colorimetric and [3H]-uridine assays for in vitro chemosensitivity testing.
Ford CH; Richardson VJ; Tsaltas G
Cancer Chemother Pharmacol; 1989; 24(5):295-301. PubMed ID: 2788039
[TBL] [Abstract][Full Text] [Related]
15. Tetrazolium [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] reduction by mycoplasmas.
Kirchhoff H; Maass C; Runge M; Franz B; Schmidt R; Quentmeier H; Mühlradt PF
Int J Syst Bacteriol; 1992 Jul; 42(3):506-8. PubMed ID: 1503978
[TBL] [Abstract][Full Text] [Related]
16. Assay of anticancer drugs in tissue culture: comparison of a tetrazolium-based assay and a protein binding dye assay in short-term cultures derived from human malignant glioma.
Haselsberger K; Peterson DC; Thomas DG; Darling JL
Anticancer Drugs; 1996 May; 7(3):331-8. PubMed ID: 8792008
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis.
Liu Y; Schubert D
J Neurochem; 1997 Dec; 69(6):2285-93. PubMed ID: 9375659
[TBL] [Abstract][Full Text] [Related]
18. On the photocatalytic reduction of MTT tetrazolium salt on the surface of TiO2 nanoparticles: Formazan production kinetics and mechanism.
Popescu T; Lupu AR; Raditoiu V; Purcar V; Teodorescu VS
J Colloid Interface Sci; 2015 Nov; 457():108-20. PubMed ID: 26164242
[TBL] [Abstract][Full Text] [Related]
19. Both oxidative stress-dependent and independent effects of amyloid beta protein are detected by 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction assay.
Abe K; Saito H
Brain Res; 1999 May; 830(1):146-54. PubMed ID: 10350568
[TBL] [Abstract][Full Text] [Related]
20. Comparison of chemosensitivity tests: clonogenic assay versus MTT assay.
Kawada K; Yonei T; Ueoka H; Kiura K; Tabata M; Takigawa N; Harada M; Tanimoto M
Acta Med Okayama; 2002 Jun; 56(3):129-34. PubMed ID: 12108583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
